Search Results - "Compton, Leigh A."

Refine Results
  1. 1

    Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update by Compton, Leigh A., Murphy, George F., Lian, Christine G.

    Published in Dermatopathology (Basel, Switzerland) (01-01-2015)
    “…Immunohistochemistry (IHC) is an important adjunct in the diagnosis of neoplastic skin diseases. In addition to the many established IHC markers currently in…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil by Que, Syril Keena T., Compton, Leigh A., Schmults, Chrysalyne D.

    “…Eruptive squamous atypia (ESA), which is an idiopathic, sometimes koebnerizing, proliferation of atypical but well-differentiated keratinocytes (also termed…”
    Get full text
    Journal Article
  5. 5

    Combined Kdm6a and Trp53 Deficiency Drives the Development of Squamous Cell Skin Cancer in Mice by Shea, Lauren K., Akhave, Neal S., Sutton, Leslie A., Compton, Leigh A., York, Conner, Ramakrishnan, Sai Mukund, Miller, Christopher A., Wartman, Lukas D., Chen, David Y.

    Published in Journal of investigative dermatology (01-02-2023)
    “…Cutaneous squamous cell carcinoma (cSCC) has among the highest mutation burdens of all cancers, reflecting its pathogenic association with the mutagenic…”
    Get full text
    Journal Article
  6. 6

    Symptomatic vulvar demodicosis: A case report and review of the literature by Hedberg, Matthew L., Chibnall, Rebecca J., Compton, Leigh A.

    Published in Journal of cutaneous pathology (01-11-2020)
    “…Demodex folliculorum is a mite that commonly inhabits the pilosebaceous units of facial skin, particularly in a perioral and periorbital distribution. While…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Coronary Vessel Development Is Dependent on the Type III Transforming Growth Factor β Receptor by Compton, Leigh A, Potash, Dru A, Brown, Christopher B, Barnett, Joey V

    Published in Circulation research (12-10-2007)
    “…Transforming growth factor (TGF)β receptor III (TGFβR3), or β-glycan, binds all 3 TGFβ ligands and inhibin with high affinity but lacks the serine/threonine…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Melanoma in a patient with DNMT3A overgrowth syndrome by Chen, David Y, Sutton, Leslie A, Ramakrishnan, Sai Mukund, Duncavage, Eric J, Heath, Sharon E, Compton, Leigh A, Miller, Christopher A, Ley, Timothy J

    Published in Cold Spring Harbor molecular case studies (01-04-2023)
    “…Alterations in epigenetic regulators are increasingly recognized as early events in tumorigenesis; thus, patients with acquired or inherited variants in…”
    Get full text
    Journal Article
  11. 11

    Advances in the Genetic Characterization of Cutaneous Mesenchymal Neoplasms: Implications for Tumor Classification and Novel Diagnostic Markers by Compton, Leigh A, Doyle, Leona A

    Published in Surgical pathology clinics (01-06-2017)
    “…Cutaneous mesenchymal neoplasms often pose significant diagnostic challenges; many such entities are rare or show clinical and histologic overlap with both…”
    Get full text
    Journal Article
  12. 12

    Transforming growth factor‐β induces loss of epithelial character and smooth muscle cell differentiation in epicardial cells by Compton, Leigh A., Potash, Dru A., Mundell, Nathan A., Barnett, Joey V.

    Published in Developmental dynamics (01-01-2006)
    “…During embryogenesis, epicardial cells undergo epithelial–mesenchymal transformation (EMT), invade the myocardium, and differentiate into components of the…”
    Get full text
    Journal Article
  13. 13

    Anticancer Therapy SMRT-ens Up: Targeting the BCL6-SMRT Interaction in B Cell Lymphoma by Compton, Leigh A., Hiebert, Scott W.

    Published in Cancer cell (13-04-2010)
    “…Transcription factors have proven to be difficult targets for the development of small-molecule drugs. In this issue of Cancer Cell, Cerchietti et al. identify…”
    Get full text
    Journal Article
  14. 14

    Advances in the Genetic Characterization of Cutaneous Mesenchymal Neoplasms by Compton, Leigh A., MD, PhD, Doyle, Leona A., MD

    Published in Surgical pathology clinics (01-06-2017)
    “…Abstract Cutaneous mesenchymal neoplasms often pose significant diagnostic challenges; many such entities are rare or show clinical and histologic overlap with…”
    Get full text
    Journal Article
  15. 15

    Coronary vessel development: the epicardium delivers by Olivey, Harold E, Compton, Leigh A, Barnett, Joey V

    Published in Trends in cardiovascular medicine (01-08-2004)
    “…Coronary artery disease accounts for 54% of all cardiovascular disease in the United States. Understanding how coronary vessels develop is likely to uncover…”
    Get full text
    Journal Article
  16. 16

    Primary and immortalized mouse epicardial cells undergo differentiation in response to TGFβ by Austin, Anita F., Compton, Leigh A., Love, Joseph D., Brown, Christopher B., Barnett, Joey V.

    Published in Developmental dynamics (01-02-2008)
    “…Cells derived from the epicardium are required for coronary vessel development. Transforming growth factor β (TGFβ) induces loss of epithelial character and…”
    Get full text
    Journal Article
  17. 17

    Isoform-Specific Effects of Charged Residues at Borders of the M1−M2 Loop of the Na,K-ATPase α Subunit by Coppi, Maddalena V, Compton, Leigh A, Guidotti, Guido

    Published in Biochemistry (Easton) (23-02-1999)
    “…The Na,K-ATPase is specifically inhibited by the cardiac glycoside, ouabain. Via a largely undefined mechanism, the ouabain affinity of the Na,K-ATPase can be…”
    Get full text
    Journal Article
  18. 18

    Migration and differentiation of epicardial cells stimulated by TGFβ1, TGFβ2, or BMP‐2 do not require the Type III Transforming Growth Factor β receptor by Austin, Anita, Compton, Leigh A, Love, Joseph D, Sanchez, Nora A, Brown, Christopher B, Barnett, Joey V

    Published in The FASEB journal (01-04-2010)
    “…Transforming Growth Factor β (TGFβ) Receptor III (TGFβR3) binds all three TGFβ ligands, inhibin, and Bone Morphogenic Protein‐2 (BMP‐2). Since TGFβ causes…”
    Get full text
    Journal Article
  19. 19

    Type III Transforming Growth Factor‐ β Receptor regulates proliferation and apoptosis in epicardial cells by Sanchez, Nora Sylvia, Austin, Anita F, Compton, Leigh A, Love, Joey D, Barnett, Joey V

    Published in The FASEB journal (01-04-2009)
    “…Abstract only Epicardial cells transform into the myocardium and form coronary vessels. The Type III Transforming Growth Factor‐ β Receptor ( Tgfbr3 ) is…”
    Get full text
    Journal Article
  20. 20

    Transforming Growth Factor‐β stimulates smooth muscle differentiation in epicardial cells lacking the Type III Receptor by Barnett, Joey V., Compton, Leigh A., Love, Joey D., Austin, Anita F.

    Published in The FASEB journal (01-03-2008)
    “…Abstract only Transforming growth factor (TGF) β receptor III (TGFβR3) binds all 3 TGFβ ligands and inhibin with high affinity but lacks the serine/threonine…”
    Get full text
    Journal Article